You are here

Minkowski Prize

The Minkowski Prize recognises research which contributes to the advancement of knowledge concerning diabetes mellitus.

To be eligible for nomination:

  • Candidates must be an EASD member
  • Candidates may be from any country
  • Candidates should be younger than 45 years in the year of nomination and/or their MD or PhD degree should have been obtained within the last 15 years. Time periods (up to two years) spent on maternity/paternity leave, in part-time employment, long-term illness or other exceptional circumstances will be taken into account, if adequate documentation is provided.

The awardee will receive a monetary prize generously sponsored by Lilly and will deliver a Lecture during the EASD Annual Meeting in the year of the award describing the awardee’s most important scientific achievements.


Learn more about the 2024 Minkowski Prize awardee:

Elisa de Franco, United Kingdom
Lecture: Finding the missing pieces of the puzzle: gene discovery in neonatal diabetes to gain new insights into beta cell biology

Awardee Portrait Video

Minkowski Awardees:

2024 Madrid
E. de Franco (UK): Finding the missing pieces of the puzzle: gene discovery in neonatal diabetes to gain new insights into beta cell biology

2023 Hamburg
T. Müller (DE): Novel insights into regulation of energy and glucose metabolism by GIP and GIPR:GLP-1R co-agonists

2022 Stockholm
M. Heni (DE): The insulin resistant brain: impact on whole-body metabolism and body fat distribution

2021 Virtual Meeting
A. Bonnefond (FR): Hunt for rare variants and pretty little things in the genetics of diabetes

2020 Virtual Meeting
G.P. Fadini (IT): Should I stay or should I go? The bone marrow and stem cell traffic in diabetes

2019 Barcelona
F.K. Knop (DK): My gut feeling about glucagon

2018 Berlin
F. Bäckhed (SE): The gut microbiota - a forgotten organ - that contributes to glucose metabolism

2017 Lisbon
E.R. Pearson (UK): Targeting therapy in diabetes: insights from genetics

2016 Munich
P. Schrauwen (NL):
Let's energise: mitochondria and energy turnover to comBAT type 2 diabetes

2015 Stockholm
M. Blüher (DE):
Size, sites and cytes: importance of adipose tissue in diabetes and beyond

2014 Vienna
A. Gloyn (UK):
Unravelling causal mechanisms in diabetes pathogenesis

2013 Barcelona
M. Cnop (BE):
The heart of the matter: beta cells in diabetes

2012 Berlin
T.M. Frayling (UK):
Human genetics and type 2 diabetes: behind the headlines

2011 Lisbon
N. Sattar (UK):
Exploiting biomarkers and large datasets for insights into diabetes and cardiovascular disease

2010 Stockholm
F. Gribble (UK):
Molecular mechanisms underlying the secretion of incretin hormones

2009 Vienna
G. Perseghin (IT):
Ectopic fat: the result of the interaction between insulin resistance and energy metabolism

2008 Rome
J.C. Brüning (DE):
Insulin action in the central nervous system: from metabolism to neurodegeneration and control of lifespan

2007 Amsterdam
M. Stoffel (CH):
Transcriptional control of metabolism in type 2 diabetes: Lessons learned from fasting and feeding

2006 Copenhagen
M. Roden (DE):
From overabundance to energy crisis

2005 Athens
P. Rossing (DK):
Progression of diabetic nephropathy: Prediction, promotion, prevention - and the pill

2004 Munich
G.A. Rutter (UK):
Orchestrating insulin secretion at the single vesicle level

2003 Paris
M. Stumvoll (DE):
Control of glycemia - from molecules to men

2002 Budapest
B.O. Roep (NL):
T-cells in the pathogenesis of type 1 diabetes: The good, the bad and the ugly

2001 Glasgow
J.R. Zierath (SE):
Insulin signalling and glucose transport in sketal muscle: Unravelling the mysteries of metabolic disease

2000 Jerusalem
H. Edlund (SE):
Factors controlling beta-cell identity and glucose homeostasis

1999 Brussels
R. Scharfmann (FR):
Control of early development of the pancreas in rodent and human

1998 Barcelona
J.H. Auwerx (FR):
PPARγ, a versatile metabolic regulator

1997 Helsinki
P. Froguel (FR):
Genetics of type 2 diabetes: Back to the future

1996 Vienna
P. Rorsman (DK):
The pancreatic beta-cell as a fuel sensor: An electrophysiologist's view point

1995 Stockholm
J. Todd (UK):
The genetics of type I diabetes: It was only a nightmare

1994 Düsseldorf
T. Mandrup Poulson (DK):
The role of interleukin-1 in the pathogenesis of insulin dependent diabetes dellitus

1993 Istanbul
H. Yki-Järvinen (FI):
Insulin action in heart, muscle and liver - from pathophysiology towards optimal therapy

1992 Prague
E. van Schaftingen (BE):
Glycolysis revisited

1991 Dublin
C. Boitard (FR):
The differentiation of the immune system towards anti-islet immunity. Clinical prospects

1990 Copenhagen
P. Halban (CH):
Proinsulin trafficking and processing

1989 Lisbon
H.-U. Häring (DE):
The insulin receptor kinase: Its role in insulin action and in the pathogenesis of type 2 (non-insulin-dependent) diabetes

1988 Paris
J.C. Hutton (UK):
The insulin secretory Granule

1987 Leipzig
J.-L. Carpentier (CH):
The cell biology of the insulin receptor interaction

1986 Rome
D. Pipeleers (BE):
Biosociology of the pancreatic beta-cell

1985 Madrid
E. Van Obberghen (FR):
Insulin receptor: from hormone recognition to cell activation

1984 London
A. Lernmark (DK):
Molecular biology of insulin dependant diabetes

1983 Oslo
S.L. Howell (UK):
The mechanism of insulin secretion

1982 Budapest
G.F. Bottazzo (UK):
B-cell damage: Are we approaching the solution?

1981 Amsterdam
P. De Meyts (BE):
The multiple affinity States of the insulin receptor and their physiological implication

1980 Athens
I.-B. Taljedal (SE):
On insulin secretion

1979 Vienna
S.J. Ashcroft (UK):
Glucoreceptor mechanisms and the control of insulin release and biosynthesis

1978 Zagreb
J. Nerup (DK):
HLA factors and autoimmunity in insulin-dependant diabetics

1977 Geneva
J. Wahren (SE):
Physical exercise and fuel homeostasis in diabetes mellitus

1976 Helsinki
K.D. Hepp (DE):
Studies on the mechanism of insulin action: Basic concepts and clinical implications

1975 Munich
P. Freychet (FR):
Interactions of polypeptide hormones with cell membrane specific receptors: Studies with insulin and glucagon

1974 Jerusalem
E. Cerasi (SE):
Mechanisms of glucose stimulated insulin secretion in health and in diabetes: Some re-evaluations and proposals

1973 Brussels
L. Orci (IT/CH):
A portrait of the pancreatic beta-cell

1972 Madrid
W.J. Malaisse (BE):
Insulin secretion: multifactorial regulation for a single process of release

1971 Southampton
C.N. Hales (UK):
Immunological techniques in diabetes research

1970 Warsaw
B. Jeanrenaud (CH):
Adipocytes, available energy and endocrine pancreas

1969 Montpellier
B. Hellman (SE):
Methodological approaches to studies on the pancreatic islets

1968 Louvain
L.A. Carlson (SE): Antilipolysis as a tool in the study of clinical and experimental diabetes

1967 Stockholm
E.R. Froesch (CH): The physiology and pharmacology of adipose tissue lipolysis: Its inhibition and implications for the treatment of diabetes

1966 Aarhus
P.J. Randle (UK): Carbohydrate metabolism and lipid storage and break-down in diabetes